SCID-AI · 405 SNS Axis Business Space, Nanpura, Surat
Mon–Sat: 11–1 PM & 4–6 PM
HIV infection — blood test and diagnosis
 Disease Guide · Medically Reviewed

HIV Infection — A Complete Medical Guide

Reviewed by Dr. Pratik Savaj, FNB Infectious Diseases, SCID-AI, Surat
Updated: May 2026
13 sections · Comprehensive reference

HIV (Human Immunodeficiency Virus) is a virus that attacks the human immune system — specifically CD4 T-cells. Without treatment, HIV progressively damages the immune system over years. With modern antiretroviral therapy (ART), HIV is a manageable chronic condition — people who start treatment early live full, normal-length lives and cannot sexually transmit the virus to their partners (U=U).

39MLiving with HIV globallyWHO 2023
2.4MLiving with HIV in IndiaNACO 2023
U=UUndetectable = UntransmittableWHO endorsed
99%+Risk reduction with PrEPWhen taken consistently
72hrWindow for PEPStart immediately after exposure
Section 01

What Is HIV?

HIV stands for Human Immunodeficiency Virus. It is a lentivirus — a type of retrovirus — that infects humans and, if untreated, causes progressive failure of the immune system. HIV was first identified in the early 1980s when clusters of unusual immune deficiency-related illnesses began appearing in previously healthy adults.

There are two types of HIV. HIV-1 is the dominant type worldwide and responsible for the global HIV pandemic. HIV-2 is found mainly in West Africa, progresses more slowly, is less easily transmitted, and has natural resistance to some ART drugs. In India, almost all HIV infections are HIV-1.

HIV is not AIDS. HIV is the virus. AIDS (Acquired Immunodeficiency Syndrome) is the advanced stage of HIV infection — defined by a CD4 count below 200 cells/mm³ or the presence of an AIDS-defining illness. With modern ART started early, the vast majority of HIV-positive people never develop AIDS.

Key Fact

HIV is a manageable chronic condition — comparable to well-controlled diabetes or hypertension. People with HIV who start treatment early live full, healthy, normal-length lives. The goal of treatment is an undetectable viral load and a normal CD4 count.

HIV vs AIDS — The Critical Distinction

HIV

The virus

 Virus attacking CD4 T-cells
 Effectively controlled with ART
 Full lifespan with early treatment
 U=U: cannot transmit when undetectable

AIDS

Advanced untreated HIV

 CD4 below 200/mm³
 Occurs only without treatment
 Entirely preventable with early ART
 Most HIV patients never reach AIDS
Dr. Pratik Savaj

Dr. Pratik Savaj

FNB Infectious Diseases · SCID-AI, Surat
Medically reviewed this guide — May 2026

HIV immune system CD4 cells
Section 02

How HIV Affects the Immune System

The immune system relies on CD4 T-lymphocytes (CD4 T-cells) — helper T-cells — to coordinate the immune response to infections. A normal CD4 count in a healthy adult is 500–1,500 cells per mm³ of blood.

HIV specifically targets cells carrying the CD4 surface receptor. The virus binds to CD4, enters the cell, and hijacks the cell's own machinery to replicate itself. It uses the enzyme reverse transcriptase to convert its RNA into DNA, then uses integrase to embed that DNA into the host cell's genome. The cell then produces new HIV particles that infect more CD4 cells.

Over time, this destroys CD4 cells. Without enough CD4 cells, the immune system cannot fight opportunistic infections — infections a healthy immune system would prevent — such as Pneumocystis pneumonia, cryptococcal meningitis, and toxoplasmosis.

How ART Blocks HIV Replication

NRTIs (Nucleoside Reverse Transcriptase Inhibitors) — block the reverse transcriptase enzyme at the nucleoside binding site. E.g. Tenofovir, Lamivudine.
NNRTIs (Non-Nucleoside RTIs) — block reverse transcriptase at a different site. E.g. Efavirenz, Rilpivirine.
INSTIs (Integrase Strand Transfer Inhibitors) — block the integrase enzyme, preventing HIV DNA from integrating into the host cell genome. E.g. Dolutegravir, Bictegravir.
Protease Inhibitors (PIs) — block the protease enzyme needed to process new HIV particles. E.g. Darunavir.

Why Combination ART Works

By combining drugs from different classes, ART suppresses HIV from multiple angles simultaneously — making it extremely difficult for the virus to develop resistance to all drugs at once. This is why modern ART, taken correctly, achieves and maintains an undetectable viral load indefinitely.

Section 03 & 04

Causes of HIV & How It Spreads

HIV is present in specific bodily fluids in concentrations high enough to cause infection. Understanding transmission accurately is essential for prevention and for ending the stigma that prevents people from seeking care.

HIV transmission routes
Bodily FluidHIV Present?Transmission Risk
BloodYes — high concentrationHigh risk
Semen & pre-seminal fluidYes — high concentrationSignificant risk (sexual transmission)
Rectal fluidYes — high concentrationHigh risk (receptive anal sex)
Vaginal fluidYes — moderate concentrationModerate risk
Breast milkYesRisk (mother to child)
SalivaTrace amounts onlyNo — not sufficient to transmit
Sweat, tears, urineNo or trace onlyNo transmission risk

HIV Spreads Through

Unprotected sexual intercourse with an HIV-positive partner not on effective ART. Anal sex (particularly receptive) carries the highest per-act risk. Consistent condoms dramatically reduce risk.
Sharing injection drug equipment — needles, syringes, or other equipment carrying HIV-positive blood.
Mother to child — during pregnancy, delivery, or breastfeeding without PMTCT interventions. Risk reduces to below 2% with proper ART.
Blood transfusion with unscreened blood — extremely rare in modern healthcare with mandatory screening.

HIV Does NOT Spread Through

Handshakes, hugging, kissing on the cheek, or any casual contact
Sharing food, water, utensils, toilets, or bathrooms
Coughing, sneezing, or breathing the same air
Insect bites — mosquitoes, flies, or any other insects
Saliva, sweat, or tears — do not contain enough HIV to transmit
Sexual contact with a person on effective ART with undetectable viral load (U=U)
U=UWHO Endorsed

Undetectable = Untransmittable

A person with HIV who is on effective ART and has maintained an undetectable viral load (below 200 copies/mL) cannot sexually transmit HIV to their partner. This is established scientific fact confirmed by the PARTNER and PARTNER2 studies (zero transmissions in thousands of condomless sex acts) and endorsed by WHO, CDC, and UNAIDS. It is the most important prevention message in modern HIV care.

Section 05

Stages & Symptoms of HIV Infection

HIV presents very differently depending on the stage of infection. Many people with HIV have no symptoms for years — testing is the only way to know your HIV status. The stages differ in viral load, CD4 count, symptoms, and infectiousness.

Stages of HIV infection
Stage 1 · Weeks 2–4

Acute HIV Infection

Seroconversion illness — lasts 1–2 weeks

 High fever (38°C+)
 Swollen lymph nodes
 Severe sore throat & mouth ulcers
 Flat red rash on trunk and face
 Severe muscle and joint pain
 Night sweats and diarrhoea
Viral load very high — most infectious stage. Antibody tests may still be negative (window period).
Stage 2 · Months to Years

Chronic HIV Infection

Clinical latency — HIV active at lower levels

 Often no symptoms for many years
 HIV still replicating and infectious
 CD4 count slowly declining
 Can last 10+ years without ART
 ART at this stage prevents all progression
 Undetectable viral load achievable (U=U)
Why regular HIV testing matters — most people in this stage feel completely healthy and don’t know they have HIV.
Stage 3 · Without Treatment

Advanced HIV / AIDS

CD4 below 200/mm³ — preventable with early ART

 Dramatic weight loss (wasting)
 Recurrent pneumonia (PCP)
 Cryptococcal meningitis
 TB co-infection (most common in India)
 Kaposi’s sarcoma, lymphoma
 ART can still help — immune recovery possible
Entirely preventable by starting ART early, before CD4 falls.
Section 06 & 07

HIV Diagnosis — Tests, Timing & the Window Period

HIV testing is the only way to know your status. Testing is recommended for everyone and is essential after a potential HIV exposure, for pregnant women, and for anyone with symptoms suggestive of HIV.

TestWhat It DetectsWindow PeriodUse
4th Gen ELISA (Ag/Ab)Antibodies + p24 antigen18–45 days; reliable 6wkFirst-line screening
Western BlotSpecific HIV protein antibodiesSame as ELISAConfirmatory
HIV RNA PCRHIV RNA (viral genetic material)10–12 daysEarly infection; newborns; ART monitoring
CD4 CountNumber of CD4 T-cells/mm³Not applicableStaging; treatment decisions; monitoring
Viral LoadCopies of HIV RNA per mL bloodNot applicableART monitoring; U=U status

Understanding the Window Period

The window period is the time between infection and when a test can reliably detect HIV. With a 4th generation test (current standard): window period 18–45 days; reliable from 6 weeks; definitive at 12 weeks. A negative result at 12 weeks conclusively rules out HIV from that exposure. If you have had a high-risk exposure, seek PEP immediately — do not wait for the window period to end.

What CD4 Count and Viral Load Mean

CD4 count measures immune damage. Normal: 500–1,500/mm³. Below 200 defines AIDS. The goal of ART is to restore and maintain CD4 above 500. Viral load measures HIV replication. The goal of ART is “undetectable” — below 50 copies/mL. Undetectable = U=U status (cannot transmit sexually).

HIV diagnostic testing laboratory
HIV antiretroviral therapy ART
Section 08

HIV Treatment — Antiretroviral Therapy (ART)

HIV cannot be cured with currently available medicines, but it can be completely controlled with antiretroviral therapy (ART). Modern ART is typically one tablet once daily. When taken correctly, ART suppresses HIV to undetectable levels indefinitely.

Everyone diagnosed with HIV should start ART — regardless of CD4 count or whether they have symptoms. Current WHO and Indian NACO guidelines recommend initiating ART on the day of diagnosis or as soon as possible. Earlier ART leads to better long-term outcomes.

The current WHO-preferred and NACO first-line regimen is TLD (Tenofovir + Lamivudine + Dolutegravir) — one tablet once daily, highly effective, well-tolerated, high barrier to resistance, and available free at all government ART centres in India.

6 Goals of ART

Undetectable Viral Load

Below 50 copies/mL — the clinical goal of treatment

Restore CD4 Count

Rebuild and maintain the immune system

Prevent Opportunistic Infections

TB, PCP, cryptococcal meningitis

U=U Status

Eliminate risk of sexual transmission

Manage Side Effects

Minimise impact on daily life

Full, Normal Lifespan

The achievable goal with early treatment

U=UWHO Endorsed

Treatment is Prevention

When viral load is suppressed to undetectable levels with ART, the virus cannot be sexually transmitted to a partner — zero risk. This is the most powerful HIV prevention tool for HIV-positive individuals in relationships.

Section 09

Living With HIV in 2026

With ART, people with HIV can work, study, travel, have relationships, and have children — living full, healthy, normal-length lives. A 20-year-old starting ART today has a life expectancy comparable to their HIV-negative peers.

Pregnancy and Family Planning

HIV-positive individuals can have children safely. PMTCT (Prevention of Mother-to-Child Transmission) interventions — ART during pregnancy, appropriate delivery management, and infant prophylaxis — reduce HIV transmission to the baby to below 2%, and in many cases to zero.

Legal Rights Under the HIV Act 2017

No disclosure without written consent — HIV status cannot be shared with employer, family, insurer, or anyone else without explicit written consent.
No employment discrimination — employers cannot take action based on HIV status. This is a criminal offence under the Act.
Right to equal healthcare — no hospital or clinic can deny care based on HIV status.
Right to informed consent — HIV testing cannot be done without knowledge and consent.

Your Confidentiality Is Legally Guaranteed

Many people delay seeking HIV testing or treatment due to fear of disclosure. Under the HIV and AIDS (Prevention and Control) Act, 2017, your HIV status is legally protected. Healthcare providers who violate confidentiality face criminal penalties. At SCID-AI, all HIV consultations are fully confidential by law and by practice.

Living with HIV — normal life with ART
Section 10

HIV & TB Co-Infection

HIV-TB co-infection

TB is the leading cause of death in people with HIV worldwide. People with HIV are 18 times more likely to develop active TB. Managing both conditions together requires specialist expertise due to drug interactions and IRIS risk.

All HIV-positive patients should be screened for TB at diagnosis and annually thereafter.
All TB patients should be offered HIV testing — co-infection changes management significantly.
Rifampicin (main TB drug) significantly lowers levels of many ART drugs — regimen adjustment is essential.
IRIS (Immune Reconstitution Inflammatory Syndrome) can occur when ART is started during active TB — timing requires specialist management.
Isoniazid preventive therapy (IPT) is recommended for all HIV-positive individuals without active TB.
Section 11

HIV Prevention

HIV prevention strategies

Modern HIV prevention is highly effective. The combination of PrEP, PEP, U=U, and consistent condoms means HIV transmission is preventable in almost all circumstances.

PrEP

Daily tablet for HIV-negative people at ongoing high risk. Reduces infection risk by 99%+ when taken consistently.

PEP

Emergency 28-day ART after high-risk exposure. Must start within 72 hours. Call immediately.

U=U

Undetectable = Untransmittable. HIV-positive people on effective ART cannot transmit HIV sexually.

PMTCT

With ART during pregnancy and infant prophylaxis, mother-to-child transmission drops below 2%.

Section 12

HIV Infection in India

India has the third-largest HIV epidemic in the world, with an estimated 2.4 million people living with HIV (NACO 2023). The adult HIV prevalence is approximately 0.20%. India’s HIV response is coordinated by NACO (National AIDS Control Organisation) under the Ministry of Health.

India’s HIV programme has achieved significant progress: new HIV infections have declined by over 46% and AIDS-related deaths by over 71% since 2010. India aims to end AIDS as a public health threat by 2030, aligned with UNAIDS 95-95-95 targets.

2.4MPeople with HIV in IndiaNACO 2023
46%Decline in new infections since 2010NACO data
600+Government ART centres nationwideFree ART available
FreeTLD regimen at all ART centresNACO programme

Free HIV Treatment in India

The Government of India provides free ART through NACO-run centres in all districts. The standard first-line regimen TLD (Tenofovir + Lamivudine + Dolutegravir) is available free. Free HIV testing, CD4 count, and viral load testing are available at government ICTC and ART centres. No patient should go without ART in India due to cost.

HIV in India — NACO programme
Section 13

Frequently Asked Questions About HIV

Common questions about HIV infection — answered clearly and medically accurately.

Is HIV the same as AIDS?
No. HIV is the virus. AIDS is the advanced stage of untreated HIV infection — defined by a CD4 count below 200 cells/mm³ or the presence of an AIDS-defining illness. With modern ART started early, the vast majority of HIV-positive people never develop AIDS. HIV is now a manageable chronic condition.
Can HIV be cured?
There is currently no cure. However, HIV can be completely controlled with antiretroviral therapy (ART). With ART, people with HIV can have an undetectable viral load, a normal CD4 count, and a full, normal-length lifespan. Research into a functional cure and vaccines is ongoing worldwide.
How long can a person live with HIV?
With modern ART started early, people with HIV have a near-normal life expectancy — comparable to the general HIV-negative population. A 20-year-old starting ART today can expect to live into their late 70s. The earlier ART is started, the better the long-term outcome.
Can an HIV-positive person have children?
Yes — safely. With proper PMTCT interventions (ART during pregnancy, appropriate delivery management, infant prophylaxis), the risk of HIV transmission to the baby can be reduced to below 2% — and in many cases to zero. HIV-positive individuals wishing to have children should plan with their HIV specialist well before conception.
What is the window period for HIV testing?
The window period is the time between infection and when a test can reliably detect HIV. With a modern 4th generation antigen/antibody test: the window period is 18–45 days; testing is reliable from 6 weeks; definitive confirmation at 12 weeks. A negative test at 12 weeks conclusively rules out HIV from that exposure.
Is free HIV treatment available in India?
Yes. The Government of India provides free ART through NACO-run ART centres in all districts. Free HIV testing at government ICTC centres. The standard first-line regimen (TLD — Tenofovir, Lamivudine, Dolutegravir) is available free. CD4 count and viral load testing are also available free or subsidised at government facilities.
What is U=U?
U=U stands for Undetectable = Untransmittable. When a person with HIV is on effective ART and their viral load is suppressed to undetectable levels (below 200 copies/mL), the virus cannot be sexually transmitted to a partner. This is established scientific fact, confirmed by large clinical studies, and endorsed by WHO, CDC, and UNAIDS. It means HIV-positive people on effective treatment pose zero risk of sexual transmission.
What should I do if I think I was exposed to HIV?
If you believe you had a high-risk HIV exposure: (1) Seek PEP immediately — it must start within 72 hours to be effective, and earlier is significantly better. (2) Get tested for HIV and other STIs. (3) Do not have unprotected sex with others until your HIV status is confirmed negative at 12 weeks. Call +91 72839 34807 or go to your nearest ICTC immediately — do not wait.
Consult Dr. Pratik Savaj

Have HIV Questions? Get Expert Answers.

No referral needed. All consultations are legally confidential under the HIV Act 2017. Dr. Pratik Savaj is an FNB-qualified infectious disease specialist with dedicated HIV training at P.D. Hinduja Hospital, Mumbai. SCID-AI, Nanpura, Surat.

SCID-AI, Nanpura, Surat — 405 SNS Axis Business Space, Besides Mahavir Hospital, Surat 395001
Mon–Sat: 11 AM–1 PM & 4–6 PM · Sunday: Closed
+91 72839 34807 — Call or WhatsApp
HIV consultation — SCID-AI, Surat